Compugen Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0010852080
USD
2.09
-0.18 (-7.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Bionano Genomics, Inc.
Cue Biopharma, Inc.
CARA Therapeutics, Inc.
Carmell Corp.
Immunome, Inc.
NGM Biopharmaceuticals, Inc.
Compugen Ltd.
Kodiak Sciences, Inc.
Anixa Biosciences, Inc.
Spruce Biosciences, Inc.
IO Biotech, Inc.

Why is Compugen Ltd. ?

1
The company has declared negative results for the last 2 consecutive quarters
  • The company has declared negative results in Dec 24 after 4 consecutive negative quarters
  • NET SALES(Q) At USD 1.89 MM has Fallen at -65.84%
  • PRE-TAX PROFIT(Q) At USD -6.94 MM has Fallen at -87.01%
  • NET PROFIT(Q) At USD -6.98 MM has Fallen at -44.16%
2
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -1.84% over the previous quarter and collectively hold 16.03% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Compugen Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Compugen Ltd.
33.12%
0.04
73.36%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
51.19%
EBIT Growth (5y)
-2.23%
EBIT to Interest (avg)
-26.16
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.81
Sales to Capital Employed (avg)
0.46
Tax Ratio
47.42%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.03%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.90
EV to EBIT
-4.01
EV to EBITDA
-4.01
EV to Capital Employed
-3.09
EV to Sales
18.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-63.02%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at -189.71 %

-28What is not working for the Company
NET SALES(Q)

At USD 1.89 MM has Fallen at -65.84%

PRE-TAX PROFIT(Q)

At USD -6.94 MM has Fallen at -87.01%

NET PROFIT(Q)

At USD -6.98 MM has Fallen at -44.16%

ROCE(HY)

Lowest at -52.95%

RAW MATERIAL COST(Y)

Grown by 84.94% (YoY

Here's what is working for Compugen Ltd.

Debt-Equity Ratio
Lowest at -189.71 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Compugen Ltd.

Net Sales
At USD 1.89 MM has Fallen at -65.84%
over average net sales of the previous four periods of USD 5.54 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -6.94 MM has Fallen at -87.01%
over average net sales of the previous four periods of USD -3.71 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -6.98 MM has Fallen at -44.16%
over average net sales of the previous four periods of USD -4.84 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Raw Material Cost
Grown by 84.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales